Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (181-190 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Thrombosis and Hemostasis|October 1, 1989
Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardizationJ Fareed, J M Walenga, D Hoppensteadt, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Synthetic substrate assays of the coagulation enzymes and their inhibitors. Comparison with clotting and immunologic methods for clinical and experimental usageH L Messmore, J Fareed, J Kniffin, et al.
Expert Opinion on Investigational Drugs|June 1, 1997
Low molecular weight heparins: a developmental perspectiveJ Fareed, D Hoppensteadt, W Jeske, et al.
Radiology|February 1, 1990
Thrombogenic potential of nonionic contrast media?J Fareed, J M Walenga, G E Saravia, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
Studies on the profibrinolytic actions of heparin and its fractionsJ Fareed, J M Walenga, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 22, 2004
Blood levels of nitric oxide, C-reactive protein, and tumor necrosis factor-alpha are upregulated in patients with malignancy-associated hypercoagulable state: pathophysiologic implicationsD Fareed, O Iqbal, M Tobu, et al.
Clinical Chemistry|February 1, 1983
Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overviewJ Fareed, H L Messmore, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Neonatal and maternal hemostasis: value of molecular markers in the assessment of hemostatic statusC R Suarez, C E Menendez, J M Walenga, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 24, 2015
Do blood constituents in varicose veins differ from the systemic blood constituents?P Poredos, A Spirkoska, T Rucigaj, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Structural studies on a biologically active hexasaccharide obtained from heparinJ Choay, J C Lormeau, M Petitou, et al.
Pageof 39

Showing results (181-190 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Thrombosis and Hemostasis|October 1, 1989
Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardizationJ Fareed, J M Walenga, D Hoppensteadt, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Synthetic substrate assays of the coagulation enzymes and their inhibitors. Comparison with clotting and immunologic methods for clinical and experimental usageH L Messmore, J Fareed, J Kniffin, et al.
Expert Opinion on Investigational Drugs|June 1, 1997
Low molecular weight heparins: a developmental perspectiveJ Fareed, D Hoppensteadt, W Jeske, et al.
Radiology|February 1, 1990
Thrombogenic potential of nonionic contrast media?J Fareed, J M Walenga, G E Saravia, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
Studies on the profibrinolytic actions of heparin and its fractionsJ Fareed, J M Walenga, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 22, 2004
Blood levels of nitric oxide, C-reactive protein, and tumor necrosis factor-alpha are upregulated in patients with malignancy-associated hypercoagulable state: pathophysiologic implicationsD Fareed, O Iqbal, M Tobu, et al.
Clinical Chemistry|February 1, 1983
Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overviewJ Fareed, H L Messmore, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Neonatal and maternal hemostasis: value of molecular markers in the assessment of hemostatic statusC R Suarez, C E Menendez, J M Walenga, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 24, 2015
Do blood constituents in varicose veins differ from the systemic blood constituents?P Poredos, A Spirkoska, T Rucigaj, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Structural studies on a biologically active hexasaccharide obtained from heparinJ Choay, J C Lormeau, M Petitou, et al.
Pageof 39